StockData
Precigen, Inc. logo

Precigen, Inc. (PGEN) stock

PGENNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 2/30
$4.29−0.01 (-0.23%)

Close on Nov 17, 2026Market cap $1.54BP/E –Yield –

Precigen total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Precigen's total debt was $93.88M at Jun 30, 2026. For fiscal 2025 it was $93.17M. Over ten years it grew 27.0% a year on average. The highest annual figure on record is $217.99M in fiscal 2019.

Annual total debt

PeriodPeriod endValueChange
FY2025Dec 31, 2025$93.17M–
FY2024Dec 31, 2024$0–
FY2023Dec 31, 2023$0-100.0%
FY2022Dec 31, 2022$86.44M-52.0%
FY2021Dec 31, 2021$179.93M+4.7%
FY2020Dec 31, 2020$171.88M-21.2%
FY2019Dec 31, 2019$217.99M+3.0%
FY2018Dec 31, 2018$211.70M+2534.0%
FY2017Dec 31, 2017$8.04M+1.1%
FY2016Dec 31, 2016$7.95M-6.8%
FY2015Dec 31, 2015$8.53M-17.8%
FY2014Dec 31, 2014$10.37M+527.3%
FY2013Dec 31, 2013$1.65M–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$93.88M–
Q1 FY2026Mar 31, 2026$93.52M–
Q4 FY2025Dec 31, 2025$93.17M–
Q4 FY2024Dec 31, 2024$0-100.0%
Q4 FY2023Dec 31, 2023$0-100.0%
Q3 FY2023Sep 30, 2023$0-100.0%
Q2 FY2023Jun 30, 2023$0-100.0%
Q1 FY2023Mar 31, 2023$13.82M-93.1%
Q4 FY2022Dec 31, 2022$86.44M-52.0%
Q3 FY2022Sep 30, 2022$82.07M-54.4%
Q2 FY2022Jun 30, 2022$198.67M+12.1%
Q1 FY2022Mar 31, 2022$201.47M+15.4%
Q4 FY2021Dec 31, 2021$179.93M+4.7%
Q3 FY2021Sep 30, 2021$180.17M-7.2%
Q2 FY2021Jun 30, 2021$177.28M-20.6%
Q1 FY2021Mar 31, 2021$174.52M-20.9%
Q4 FY2020Dec 31, 2020$171.88M-21.2%
Q3 FY2020Sep 30, 2020$194.22M-9.9%
Q2 FY2020Jun 30, 2020$223.31M+4.9%
Q1 FY2020Mar 31, 2020$220.62M+2.8%
Q4 FY2019Dec 31, 2019$217.99M+3.0%
Q3 FY2019Sep 30, 2019$215.47M+17.3%
Q2 FY2019Jun 30, 2019$212.95M+2643.5%
Q1 FY2019Mar 31, 2019$214.57M+2607.2%
Q4 FY2018Dec 31, 2018$211.70M+2534.0%
Q3 FY2018Sep 30, 2018$183.68M+2164.3%
Q2 FY2018Jun 30, 2018$7.76M-4.4%
Q1 FY2018Mar 31, 2018$7.93M-0.9%
Q4 FY2017Dec 31, 2017$8.04M+1.1%
Q3 FY2017Sep 30, 2017$8.11M-3.7%
Q2 FY2017Jun 30, 2017$8.12M–
Q1 FY2017Mar 31, 2017$8.00M–
Q4 FY2016Dec 31, 2016$7.95M–
Q3 FY2016Sep 30, 2016$8.42M–

More Precigen figures

See a number that looks wrong?